SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-019455
Filing Date
2023-05-30
Accepted
2023-05-30 16:05:42
Documents
12
Period of Report
2023-05-23
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 38778
  Complete submission text file 0001493152-23-019455.txt   214550

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE invo-20230523.xsd EX-101.SCH 3245
3 XBRL LABEL FILE invo-20230523_lab.xml EX-101.LAB 34916
4 XBRL PRESENTATION FILE invo-20230523_pre.xml EX-101.PRE 22801
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3643
Mailing Address 5582 BROADCAST COURT SARASOTA FL 34240
Business Address 5582 BROADCAST COURT SARASOTA FL 34240 (978) 878-9505
INVO Bioscience, Inc. (Filer) CIK: 0001417926 (see all company filings)

IRS No.: 204036208 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39701 | Film No.: 23976337
SIC: 3841 Surgical & Medical Instruments & Apparatus